MedPath

Baseline-characteristics of Patients Referred to a Secondary Spine Centre

Completed
Conditions
Spine Disease
Spinal Disease
Demography
Characteristics Disease
Registration Number
NCT04877470
Lead Sponsor
Zuyderland Medisch Centrum
Brief Summary

A retrospective cohort study will be conducted in Zuyderland Medical Centre Heerlen, the Netherlands. All patients that were referred to the spine-centre between 01.01.2019 and 31.12.2019 will be included for analysis.

This study aims to evaluate baseline characteristics, including baseline questionnaires, and information about the given treatments for all patients referred to the spine centre.

Detailed Description

The incidence of back and neck pain is increasing in our ageing population. Back pain is amongst the conditions with the highest burden of disease in terms of years lived with disability (YLD). The majority of people experiences at least one period of back pain in their lifetime. The incidence of back complaints increases with age. Due to ageing of the population, the number of patients with back pain exponentially increases. Since 1980, the global population of people older than 60 years has doubled and this number is expected to double again by 2050. Patients with back or neck pain and/or symptoms of radiculopathy, and suspected spinal pathology, are often referred to a secondary spine centre. A large number of these patients will receive conservative treatment and only a small number eventually receives a surgical intervention. There is a broad array of conservative treatment options, including medication, manipulative care, physical therapy, treatment by pain specialists, and rehabilitation. The increasing incidence of spinal pathologies likewise leads to an increase in spinal surgeries. The ageing population is one of the most prominent factors by which the number of spine surgeries has increased and will even increase further in the future. Previous studies concerning the national US bill for spine related care in 2006 estimated that direct medical expenditures were over $85 billion. Over the last decades, the costs of spine related healthcare have increased at an alarming rate and will even increase further. To limit the increase of healthcare-related costs concerning spine-related healthcare in an ageing population, the selection and profiling of subgroups of patients requiring different types of treatment should be ameliorated to optimize spinal care. To date, adequate knowledge on baseline characteristics is lacking, and thereby insufficient to perform patient profiling.

This study aims to evaluate baseline characteristics, including baseline questionnaires, and information about the given treatments for all patients referred to the spine centre. Insight in the specific characteristics of different patient groups, for example different types of conservative interventions or conservative versus surgical interventions, could provide a valuable insight during counselling.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4855
Inclusion Criteria
  • Newly referred patients visiting the spine-centre at Zuyderland Medical Centre Heerlen in 2019, from 01.01.2019 until 31.12.2019.
  • Minimum age of 18 years.
  • Documented treatment (surgical or conservative).
Exclusion Criteria
  • Documented objection to participate in scientific research.
  • No baseline questionnaires available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Smoking (current status)01.01.2019-31.12.2019

Yes/no

Duration of symptoms01.01.2019-31.12.2019

Time since onset of symptoms in months.

Diagnosis01.01.2019-31.12.2019

Final diagnosis as mention in the patient file, e.g. lytic spondylolisthesis, herniated disc etc.

Age01.01.2019-31.12.2019

Age in years.

Use of pain medication01.01.2019-31.12.2019

Paracetamol, NSAID, opioid, neuropathic pain medication

Gender01.01.2019-31.12.2019

Male, female, other

History of spinal surgery01.01.2019-31.12.2019

Spinal surgeries in the past, as mentioned in the patient file, e.g. lumbar interbody fusion, discectomy, etc.

Diagnostics tests carried out01.01.2019-31.12.2019

Diagnostics as mentioned in the patient file, e.g. MRI, CT-scan, X-ray, EMG, etc.

Number of consultations01.01.2019-31.12.2019

Number of consultations at the spine-centre since referral.

Reason for referral01.01.2019-31.12.2019

Reason for referral, as mentioned in the general practitioner's file, e.g. persistent back pain, leg pain, etc.

Follow-up period01.01.2019-31.12.2019

Time between the first consultation and the last follow-up consultations, in months.

Body Mass Index (BMI)01.01.2019-31.12.2019

BMI = kg/m2

Type of complaints01.01.2019-31.12.2019

Back pain, leg pain, arm pain or neck pain

Secondary Outcome Measures
NameTimeMethod
Tampa Scale of Kinesiophobia01.01.2019-31.12.2019

Score: 17-68. 17 means no kinesiophobia, 68 means severe kinesiophobia

Örebro Musculoskeletal Pain Screening Questionnaire01.01.2019-31.12.2019

Score: 0-210. A higher score indicated more complaints and more disability.

EuroQol 5D01.01.2019-31.12.2019

Score per item, total score is based on Value Sets. A lower score indicated a better quality of life.

Roland Disability Questionnaire01.01.2019-31.12.2019

Score: 0-24. A higher score indicated more disability.

Western Ontario and McMaster Universities Osteoarthritis Index01.01.2019-31.12.2019

Score: 0-96. A higher score indicates more complaints and disability.

Oswestry Disability Index01.01.2019-31.12.2019

Score: 0-100 . A higher scores indicated more disability.

Visual Analogue Scale (VAS)01.01.2019-31.12.2019

Score: 0-10. 0 is no pain, 10 is maximum pain

Oxford Hip Score01.01.2019-31.12.2019

Score: 12-60. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.

Trial Locations

Locations (1)

Zuyderland MC

🇳🇱

Heerlen, Limburg, Netherlands

Zuyderland MC
🇳🇱Heerlen, Limburg, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.